MILRINONE LACTATE and OFF LABEL USE

Overview

OFF LABEL USE is the #7 most commonly reported adverse reaction for MILRINONE LACTATE, manufactured by Baxter Healthcare Corporation. There are 10 FDA adverse event reports linking MILRINONE LACTATE to OFF LABEL USE. This represents approximately 1.7% of all 574 adverse event reports for this drug.

Patients taking MILRINONE LACTATE who experience off label use should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

OFF LABEL USE10 of 574 reports

OFF LABEL USE is a less commonly reported adverse event for MILRINONE LACTATE, but still significant enough to appear in the safety profile.

Other Side Effects of MILRINONE LACTATE

In addition to off label use, the following adverse reactions have been reported for MILRINONE LACTATE:

DRUG INEFFECTIVE — 89 reports
HYPOTENSION — 15 reports
RENAL FAILURE — 13 reports
CARDIAC FAILURE — 12 reports
DYSPNOEA — 11 reports
CARDIAC ARREST — 10 reports
VENTRICULAR TACHYCARDIA — 10 reports
HAEMORRHAGE — 9 reports
MULTI ORGAN FAILURE — 9 reports
NAUSEA — 9 reports

Other Drugs Associated with OFF LABEL USE

The following drugs have also been linked to off label use in FDA adverse event reports:

0XYGEN ABACAVIR SULFATE ABATACEPT ABIRATERONE ACETATE ACALABRUTINIB ACETAMINOPHEN ACETAMINOPHEN 500MG ACETAMINOPHEN AND CODEINE ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE ACETAMINOPHEN AND IBUPROFEN ACETAMINOPHEN AND PHENYLEPHRINE HYDROCHLORIDE ACETAMINOPHEN, ASPIRIN, AND CAFFEINE ACETAMINOPHEN, ASPIRIN, CAFFEINE ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE ACETAMINOPHEN, CAFFEINE ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE ACETAMINOPHEN, IBUPROFEN

Does MILRINONE LACTATE cause OFF LABEL USE?

OFF LABEL USE has been reported as an adverse event in 10 FDA reports for MILRINONE LACTATE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is OFF LABEL USE with MILRINONE LACTATE?

OFF LABEL USE accounts for approximately 1.7% of all adverse event reports for MILRINONE LACTATE, making it a notable side effect.

What should I do if I experience OFF LABEL USE while taking MILRINONE LACTATE?

If you experience off label use while taking MILRINONE LACTATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.